Death

Canadians’ Confidence in Personal Finances, Debt Repayment Abilities Reaches Lowest Level Ever Recorded

Retrieved on: 
Monday, January 17, 2022 - 11:03am
Ageing, Licensed insolvency trustee, DIY, Population, Adult, MNP, Optimism, Black Friday, Death, GLOBE, Trustee, Â, Reading, Anxiety, Employment, MNP LLP, Pressure, Coronavirus, Omicron, COVID, Bank, Health insurance, Security (finance), Ipsos, Index, Census

CALGARY, Alberta, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Canadians are showing record-low confidence levels when it comes to their personal finances and debt repayment abilities. The MNP Consumer Debt Index, now in its 19th wave, has reached the lowest point since inception, plummeting seven points since last quarter to 88 points. Conducted quarterly by Ipsos on behalf of MNP LTD, the Index tracks Canadians’ attitudes about their debt situation and their ability to meet their monthly payment obligations.

Key Points: 
  • CALGARY, Alberta, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Canadians are showing record-low confidence levels when it comes to their personal finances and debt repayment abilities.
  • The MNP Consumer Debt Index, now in its 19th wave, has reached the lowest point since inception, plummeting seven points since last quarter to 88 points.
  • Fewer than three in ten (27%, -2pts) are confident in their ability to cope with life-changing events without increasing their debt burden.
  • For regular, bite-sized insights about debt and personal finances, subscribe to the MNP 3 Minute Debt Break Podcast .

Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill

Retrieved on: 
Monday, January 17, 2022 - 12:00pm
Amlodipine, III, Indapamide, Patient, Research, Imperial College Healthcare NHS Trust, Academic clinical trial, George Institute for Global Health, Clinical trial, Pharmacology, International Society, Infarction, COVID-19, Guideline, Vascular dementia, Medical school, Safety, Death, Faculty, CEO, Stroke, World, School, NHS, Public health, Industry, Blood pressure, Imperial College Faculty of Medicine, Loma Linda University School of Public Health, Department of Nutrition, Cardiovascular disease, Type 2 diabetes, Heart, WHO, Medicine, Telmisartan, GP, International Society on Hypertension in Blacks, World Health Organization, Global Health, ICTU, Imperial College London, Hospital, Degenerative disease, Pharmaceutical industry, Hypertension

The phase III trial is the final stage of development, with results expected to support a regulatory filing for approval.

Key Points: 
  • The phase III trial is the final stage of development, with results expected to support a regulatory filing for approval.
  • Professor Ray leads a team of highly experienced operational staff to deliverexcellence in clinical trial management.
  • We are delighted to collaborate with Imperial Clinical Trials Unit to expand our research into the UK, where high blood pressure remains a significant silent killer and many patients are still uncontrolled.
  • A therapy that can more effectively control a patients blood pressure and reduce the significant pill burden that can lead patients to discontinue therapy could help transform how we treat high blood pressure.

Global Liver Cancer Diagnostics Market (2021 to 2028) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Monday, January 17, 2022 - 11:40am
Health, Oncology, List of health departments and ministries, CAGR, Ministry, Liver cancer, Patient, Mortality, NGS, Adoption, Death, Population, Disease, Cancer, Hepatitis B virus, Experiment, Cleveland Clinic, Cirrhosis, Diagnosis, WHO, HBV, Hepatocellular carcinoma, USD, HCC, HCV, Infection, FDA, Prevalence, Hospital, Endoscopy, Awareness, Medical imaging, Biopsy

The "Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Type (Laboratory Tests, Imaging Tests, Endoscopy, Biopsy), by End-use, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Type (Laboratory Tests, Imaging Tests, Endoscopy, Biopsy), by End-use, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global liver cancer diagnostics market size is expected to reach USD 17.4 billion by 2028.
  • The rising prevalence of liver cancer and the introduction of innovative diagnosis products are propelling the market growth.
  • The most common cause of liver cancer is chronic (long-term) infection with Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV).

Praxis by Landmark Recovery Brings Medicaid Addiction Treatment Options to the Firelands

Retrieved on: 
Monday, January 17, 2022 - 12:00pm
Professional Services, Mental Health, Health, Hospitals, Insurance, Managed Care, General Health, Fentanyl, Patient, Death, No, Drug, Medicaid, Â, Center, Taiwan Centers for Disease Control, Firelands, Multimedia, Hospital, Methamphetamine, Newsweek, Praxis

Praxis by Landmark Recovery will bring much needed addiction treatment services to the Ohio community this week by opening the doors to its new Medicaid addiction treatment center, Praxis of the Firelands .

Key Points: 
  • Praxis by Landmark Recovery will bring much needed addiction treatment services to the Ohio community this week by opening the doors to its new Medicaid addiction treatment center, Praxis of the Firelands .
  • View the full release here: https://www.businesswire.com/news/home/20220117005051/en/
    The influx of fentanyl and methamphetamine in the market has unfortunately created significant demand for addiction treatment services, said Matt Boyle, the chief executive officer of Landmark Recovery.
  • About Praxis by Landmark Recovery:
    Praxis by Landmark Recovery, founded in 2016, is an evidence-based addiction recovery organization serving the Medicaid population.
  • Praxis serves communities in Kentucky, Indiana, and Ohio along with its sister company, Landmark Recovery, which serves the private insurance community nationwide.

Global Immunoassay Markets 2021-2028 - Introduction of PoC Rapid Tests and Automated Immunoassay Analyzers is Driving Market Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, January 17, 2022 - 10:48am
Health, Other Health, Well, National Cancer Institute, CAGR, Myocardial infarction, Application, Antigen, EIA, Incidence, Enzyme immunoassay, POC, Antibody, SRL Diagnostics, COVID-19, Malaria, American Cancer Society, Death, RIA, Software, Infection, HIV, WHO, Reagent, USD, Cancer, Smartphone, ELISA, Awareness, Medical device, Vaccine, Dietary supplement, Technology

The global immunoassay market size is expected to reach USD 36.7 billion by 2028 and is expected to expand at a CAGR of 6.7% from 2021 to 2028.

Key Points: 
  • The global immunoassay market size is expected to reach USD 36.7 billion by 2028 and is expected to expand at a CAGR of 6.7% from 2021 to 2028.
  • The introduction of PoC rapid tests and automated immunoassay analyzers is driving the market growth.
  • In addition, the rising number of chronic and infectious diseases is also leading to high market growth.
  • Several smartphone-based devices and associated tools have emerged as next-generation point-of-care diagnostics or testing devices, boosting the market growth.

Global Air Ambulance Services Market (2021 to 2027) - Featuring Acadian Ambulance Services, Air Methods and Falck Holding Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, January 17, 2022 - 9:30am
Hospitals, Air, Health, Transport, Transfer, CAGR, Patient, Research, MERS, COVID-19, Ambulance, Travel, Adoption, SARS, Death, Government, World, Pandemic, Accident, Joint Medical Service (Germany), World Health Organization, Infection, REVA, Hospital, Transport, Airline, Marketing, H1N1

The global air ambulance services market is anticipated to grow at a substantial CAGR of 12.2% during the forecast period.

Key Points: 
  • The global air ambulance services market is anticipated to grow at a substantial CAGR of 12.2% during the forecast period.
  • Such pandemics will give a significant boom to the global air ambulance services market.
  • The major companies serving the global air ambulance services market include Acadian Ambulance Services, Inc., Air Methods Corp., Falck Holding A/S, IAS Medical, Ltd., PHI Group, Inc., REVA, Inc., and others.
  • Insights about market determinants that are stimulating the global air ambulance services market.

Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill

Retrieved on: 
Monday, January 17, 2022 - 7:00am
Amlodipine, III, Indapamide, Patient, Research, Imperial College Healthcare NHS Trust, Academic clinical trial, George Institute for Global Health, Clinical trial, Pharmacology, International Society, Infarction, COVID-19, Guideline, Vascular dementia, Medical school, Safety, Death, Faculty, CEO, Stroke, World, School, NHS, Public health, Industry, Blood pressure, Imperial College Faculty of Medicine, Loma Linda University School of Public Health, Department of Nutrition, Cardiovascular disease, Type 2 diabetes, Heart, WHO, Medicine, Telmisartan, GP, International Society on Hypertension in Blacks, World Health Organization, Global Health, ICTU, Imperial College London, Hospital, Degenerative disease, Pharmaceutical industry, Hypertension

The phase III trial is the final stage of development, with results expected to support a regulatory filing for approval.

Key Points: 
  • The phase III trial is the final stage of development, with results expected to support a regulatory filing for approval.
  • Professor Ray leads a team of highly experienced operational staff to deliverexcellence in clinical trial management.
  • We are delighted to collaborate with Imperial Clinical Trials Unit to expand our research into the UK, where high blood pressure remains a significant silent killer and many patients are still uncontrolled.
  • A therapy that can more effectively control a patients blood pressure and reduce the significant pill burden that can lead patients to discontinue therapy could help transform how we treat high blood pressure.

Statement from Bea Bruske on the death of Alexa McDonough

Retrieved on: 
Saturday, January 15, 2022 - 3:55pm
House, Mount Saint Vincent University, NDP, Social justice, Alexa, Order, Death, GLOBE, Leadership, Westray Mine, Member of the Legislative Assembly, Â, Parliamentary opposition, Commons, Women in the House of Commons of the United Kingdom, Labour, Congress, Official Opposition Shadow Cabinet of the 40th Parliament of Canada, New Democrats, Canadian Labour Congress, Politics, Family, Friends, Animal, Public relations, Woman, Africville, Westray

OTTAWA, Jan. 15, 2022 (GLOBE NEWSWIRE) -- Bea Bruske, President of the Canadian Labour Congress, released the following statement today:

Key Points: 
  • OTTAWA, Jan. 15, 2022 (GLOBE NEWSWIRE) -- Bea Bruske, President of the Canadian Labour Congress, released the following statement today:
    It was with great sadness that I learned of the death of Alexa McDonough, a true Canadian political giant.
  • There is not a woman in Canadian politics or public life who does not owe a debt to the trailblazing role Alexa has played.
  • Alexa was someone who had an abundance of dedication, and never one to shy away from hard work or a difficult fight.
  • Labour unions worked to help honour her in 2013, raising funds to make sure Alexas contributions were permanently recognized at Mount Saint Vincents Alexa McDonough Institute for Women, Gender and Social Justice.

Zymeworks Reports Inducement Grant Under New York Stock Exchange Listed Company Manual Rule

Retrieved on: 
Saturday, January 15, 2022 - 1:30pm
Oncology, Health, General Health, Research, Science, Pharmaceutical, Biotechnology, Disability, Patient, HER2, Conjugation, Inc., NYSE, Option, Death, Zymeworks, Drug development, Employment, Twitter, Engineering, Security (finance), Fine chemical

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported, as required by the New York Stock Exchange Listed Company Manual Rule 303A.08 (the NYSE Rule), an equity inducement award to Mr. Kenneth Galbraith, Zymeworks new Chair, President and Chief Executive Officer.

Key Points: 
  • Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported, as required by the New York Stock Exchange Listed Company Manual Rule 303A.08 (the NYSE Rule), an equity inducement award to Mr. Kenneth Galbraith, Zymeworks new Chair, President and Chief Executive Officer.
  • In accordance with the NYSE Rule, Zymeworks approved the grant of the following equity award to Mr. Galbraith as a material inducement to Mr. Galbraith entering into employment with Zymeworks: effective as of the date his employment with Zymeworks began, a stock option to purchase 500,000 of the companys common shares (the Options).
  • Mr. Galbraiths employment with the company began on January 15, 2022 (the Start Date).
  • Zymeworks suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates.

10 richest men double their fortunes in pandemic while incomes of 99 per cent of humanity fall

Retrieved on: 
Monday, January 17, 2022 - 12:30am
Income, Woman, World, Inequality, Colonialism, Stockholm Environment Institute, Research, Institute, Paris, Man, Vaccine, Carbon, Poverty, Bernard Arnault, African Americans, COVID-19, CRB, Parity, Death, WEF, IMF, Violence, Oxfam, School-related gender-based violence, Zoltan Sarosy, Hunger, Billionaire, Government, Female, White, Home Office hostile environment policy, Tax, Office for National Statistics, SEI, CERB, Heart, Life expectancy, Wildfire, Tornado, Statistics, Fallout 4 downloadable content, Climate change, GDP, OECD, World Economic Forum, Claw, Flood, List of national and international statistical services, World Bank, Policy, Renewable energy, Agriculture, Animal, Pharmaceutical industry, Drug, Creative industries, Restaurant, Forbes

Billionaires' wealth has risen more in the 22 months since COVID-19 began than it has in the last 14 years.

Key Points: 
  • Billionaires' wealth has risen more in the 22 months since COVID-19 began than it has in the last 14 years.
  • All this, while still leaving these men $10 billionbetter off than they were before the pandemic.
  • The world's response to the pandemic has unleashed this economic violence particularly acutely across racialized, marginalized and gendered lines.
  • The 252 richest men have more wealth than all one billion women and girls in Africa, Latin America and the Caribbean combined.